President Trump Announces Deal to Lower Cost of Weight Loss Drugs

Deal for Affordable Weight Loss Medications

• 🤝 President Trump has announced a significant deal with two major pharmaceutical companies, Novo Nordisk and Eli Lilly, to reduce the cost of popular weight loss drugs.
• 💊 Medications like Wegovy and Zepbound, described as life-changing but previously costing over $1,000 per month, will see drastic price reductions.
• 💰 The average price for a one-month supply is set to drop to approximately $350, with a future goal of reaching $245 for direct consumers.

Impact and Access Expansion

• 📈 This agreement offers new hope for individuals like Jeremy Bushy, who had to stop taking an obesity drug due to affordability issues after losing 37 pounds.
• 🎯 The deal aims to improve access and affordability for these effective medications, especially for the over 100 million obese adults in the US.
• Medicare patients will also see expanded coverage for these drugs, known as GLP1s, as part of the new agreement.

New Distribution Channels

• 💻 The drugs will become available through a new administration website, Trump RX, starting next year.
• ⚠️ A note indicates that the lowest price of $150 a month will be contingent on FDA approval for the pill forms and will apply only to the lowest doses.